Promimic AB (publ) (PRO.ST) Research

Promimic AB (publ) is dedicated to developing, commercializing, and supplying specialized biomaterials designed to enhance the integration of bone with orthopedic and dental implants. A core offering is its proprietary HAnano surface technology, an innovative solution that integrates a range of characteristics known to significantly optimize bone-to-implant bonding into a single, distinct surface modification. Established in 2004, the company's operations are headquartered in Mölndal, Sweden.

Market snapshot

Symbol
PRO.ST
Price
$10.20
Day change
-1.92%
Market cap
$192.7M
P/E ratio
-25.11x
52-week range
8.14-21.1
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Acarix AB (publ) (ACARIX.ST)
  • AlzeCure Pharma AB (publ) (ALZCUR.ST)
  • Boule Diagnostics AB (publ) (BOUL.ST)
  • Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
  • Elicera Therapeutics AB (publ) (ELIC.ST)
  • Integrum AB (publ) (INTEG-B.ST)
  • Mentice AB (publ) (MNTC.ST)
  • Nanexa AB (publ) (NANEXA.ST)

Open Promimic AB (publ) (PRO.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.